📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility. (2014)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scisignal.2005157

PubMed Identifier: 25140053

Publication URI: http://europepmc.org/abstract/MED/25140053

Type: Journal Article/Review

Volume: 7

Parent Publication: Science signaling

Issue: 339

ISSN: 1945-0877